ARRIVENT BIOPHARMA INC
AVBPNASDAQ🏆 #2265 by market capEarnings Nov 16US Equity
$29.54▲ $0.24 (+0.82%)
🌙 After hours$30.80▲ 4.27%Regular close · extended-hours price shownTrack AVBP
Get earnings, price moves & breaking news on Telegram
24h▲ 0.8%
7d▼ 2.4%
14d▲ 6.6%
30d▼ 1.7%
ytd▲ 46.7%
1y▲ 59.6%
🏦Market Cap
$1.38B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
60
Fair
ARRIVENT BIOPHARMA INC
AVBPAnalyst Ratings
Price
$29.54
Total
8
Raised
0
Lowered
0
Avg PT
$46.00
H / L
$47 / $45
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-08-17 | — | — |
BTIG | Reiterated | Buy | 2026-08-13 | $45.00 | +52.30% |
Guggenheim | Reiterated | Buy | 2026-08-13 | — | — |
Citigroup | Reiterated | Buy | 2026-08-13 | $36.00 | +21.90% |
Truist Securities | Reiterated | Buy | 2026-05-29 | — | — |
B. Riley Securities | Reiterated | Buy | 2026-03-23 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-03-06 | $35.00 | +18.50% |
Goldman Sachs | Reiterated | Buy | 2024-09-10 | $33.00 | +11.70% |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-08-17
—
—
BTIG
Reiterated · Buy · 2026-08-13
$45.00
+52.30%
Guggenheim
Reiterated · Buy · 2026-08-13
—
—
Citigroup
Reiterated · Buy · 2026-08-13
$36.00
+21.90%
Truist Securities
Reiterated · Buy · 2026-05-29
—
—
B. Riley Securities
Reiterated · Buy · 2026-03-23
—
—
Oppenheimer
Reiterated · Outperform · 2026-03-06
$35.00
+18.50%
Goldman Sachs
Reiterated · Buy · 2024-09-10
$33.00
+11.70%
One row per institution · price target from the firm's latest published target